Abstract
Introduction

Although there is a great potential for stem cell therapy for regeneration of injured myocardium, major challenge remains the low rate of survival and differentiation of the implanted cells to the injured myocardium. In fact, majority of the implanted stem cells do not survive beyond a few hours [1-3]. The leading cause of cell death after implantation is the microenvironment of the injured tissue including oxidative stress, inflammatory response and development of pro-apoptotic factors. Several attempts have been made to improve the stem cell survival after the cell therapy
. For example, atorvastin treatment was found to improve the survival and effects of implanted mesenchymal stem cells in postinfarct swine hearts [7] . In another study, haemeoxygenase modified the stem cells to increase their survival [8] . In a more recent study, Pim-1 kinase overexpression modified the cardiac progenitor cell activities [9] . Thus, protection of the implanted cells from the adverse environment of the injured tissue is of utmost importance for a successful cell therapy.
Recently, we were successful in improving survival, homing and engraftment of cardiac stem cells transplanted into the infarcted myocardium by changing the oxidizing environment of the heart into a reducing environment with resveratrol, a redox sensitive polyphenolic antoxidant [10] . In that study, a group of rats were fed resveratrol for a period of 21 [12] . The obtained specimens (5-m cuts) were processed for immunofluorescence analysis as described previously [12] . (Fig. 1A-D in green) .
Immunofluorescence and confocal microscopy
Heart tissue samples were collected at the end of experiments: (1) control [implant of resveratrol-non-treated cardiac stem cells (EGFP-labelled) only without the LAD occlusion] and pre-treatment with reservatrol); (2) LAD occlusion followed by implantation with resveratrol-treated cardiac stem cells (EGFP-labelled), fixed in 2% buffered paraformaldehyde (pH 7.4), embedded and frozen in O.C.T. compound, and subjected to cryosectioning
The primary antibody against (i) p65-B (mouse monoclonal IgG), (ii) Nrf2 (nuclear factor E2-related factor) (rabbit polyclonal IgG), (iii) myosin (rabbit polyclonal IgG), (iv) Ref-1 (redox effector factor 1) (rabbit polyclonal IgG) and (v) SDF-1 (goat polyclonal
We hypothesized that adaptive enhancement of the resveratroltreated implanted cells was because of improvement of their resistance to stress factors including oxidative stress. To assess the activity of redox-sensitive signalling pathways and respective proliferative activity of the implanted cells, we analysed the nuclear localization of Nrf2, Ref-1, p65 subunit of NFB (nuclear factor B) using confocal immunofluorescence microscopy. As [12] .
Fig. 1 Immunofluorescence assessment of redox signalling and proliferative activity of EGFP-positive cardiac stem cells at day 7 after implantation. (A-C) Projections of nuclear factors Nrf2 (in red), Ref-1 (in red), and p65-B (in red) respectively in the rat heart specimens from animals subjected to LAD occlusion and implanted with resveratrol-treated cell. EGFP cells appear in green. Localizations of Nrf2, Ref-1, p65-B (in red) in the nuclei (in blue) are indicated with white arrows. (D) Projection of Ki67 in the rat heart specimens from animals subjected to LAD occlusion and implanted with resveratrol-treated cell. Localization of Ki67 (in red) is indicated with white arrows. demonstrated previously, this technique provides a great deal of reliable data compared to results from immunoblot assessment of the nuclear fraction of the same proteins
The data presented in Figure 1 Figure 2A and B were 0.014 and 0.16, respectively. The EGFP-positive cells in the LAD occlusion specimens were characterized by a pronounced expression of Ki67 protein (Fig. 2E and F) compared to the control (Fig. 2D) . Figure 3D (control) and H (LAD occlusion) were 0.07 and 0.52, respectively. Similar effect was demonstrated for the p65 subunit of B (Fig. 4A-C) that was accompanied by substantial elevation of Ki67 expression in EGFP-positive cells (Fig. 4D-F) .
demonstrate that the EGFPpositive cells have increased nuclear level of Nrf2 (panel A, in red, indicated with arrows). Regulation of redox signalling by Nrf2 could also be regulated by Ref-1, which similarly to Nrf2 can bind to antioxidant response elements and interacts with NFBessential for protection against cardiac infarction. Nuclear localization of Ref-1 and p65-B in EGFP-positive implanted cells is shown in Figure 1B and C (in red, indicated with arrows), respectively. That effect was accompanied by substantial elevation of Ki67 expression in EGFP-positive cells as compared to the host cells (panel D, in red, indicated with arrows), where Ki67 expression was used as an index of cell proliferative activity. In the second set of experiments we analysed the effect of the treatment of the EGFP-labelled cells with resveratrol on their engraftment and therapeutic efficacy after 4 months following the LAD occlusion and implantation. High number of the EGFPexpressing cells were consistently present in the myocardium when the cells were pre-treated with resveratrol as compared to control (Figs 2, 4, 5, in green). Moreover, we observed the resveratrol-induced prolonged alterations on the redox status in these cells that was determined by assessment of responses of nuclear factors Nrf2, Ref-1 and NFB. The data presented in Figure 2A-C show that the nuclear localization of Nrf2 was significantly increased in the group of LAD occlusion followed by implant with resveratrol-treated cardiac stem cells (compared to the control group implanted with resveratrol-non-treated cells). The indexes of spatial correlation 'r' of Nrf2 immunoreactivity with nuclei for the projections presented in
Fig. 2 Immunofluorescence assessment of the combined response of Nrf2 and Ki67 in cardiac tissue after 4 months following implantation of cardiac stem cells. (A, B) Projections of Nrf2 in the rat heart specimens from control (i.e. implantation of resveratrol-non-treated cells) and the LAD occlusion implanted with resveratrol-treated cell groups, respectively. (C) 3ϫ zoom of the selected area indicated in (B). Stem cells (in green) were labelled with EGFP as indicated in Materials and Methods. Localization of Nrf2 (in red) in the nuclei (in blue) is indicated with white arrows. (D, E) Projections of Ki67 in the rat heart specimens from control and the LAD occlusion implanted with resveratroltreated cell groups, respectively. (F) 3ϫ zoom of the selected area indicated in (E). Localization of Ki67 (in red) in the nuclei (in blue) is indicated with white arrows. The experimental conditions for the specimen processing, data acquiring, and image presenting are described in Materials and Methods.
Nuclear localization of Ref-1 in EGFP-positive implanted cells is shown in Figure 3. We have found that the resveratrol-treatment procedure results in a prolonged increase in the Ref-1/nuclear interaction in hearts subjected to infarction. Thus, the indexes of spatial correlation 'r' of Ref-1 immunoreactivity with nuclei for the projections presented in
We have found that these proliferating EGFP-labelled cells show also immunoreactivity to the stroma-derived factor 1 (SDF-1), a marker of the mesenchymal cardiac precursors (Fig. 5A-D) , suggesting a beneficial effect of pre-treatment with resveratrol on the engraftment of cardiac stem cells implanted to the myocardium subjected to LAD occlusion. Efficacy of engraftment of the implanted cells was documented by increase in immunoreactivity of myosin (Fig. 5E-H) and presence of immunoreactivity of c-Kit in the infarcted myocardium (Fig. 6) 
M-mode echocardiography
The echocardiography data echoed the results of cardiac regeneration (Fig. 7) . M-mode echo cardiogram of rats recorded at [13] . In another study, transfection of the cells with Bcl-2 before injection to the infarcted heart, induced 1.2-fold increase in cell survival, 15% higher capillary density in infarct border zone and 17% smaller infarct size than control hearts [14] . As mentioned earlier, in a recent study, a group of rats were fed resveratrol, and when cardiac stem cells were injected into the infarcted myocardium, the cells survived up to a period of 30 days, and performed proliferation and differentiation leading to the regeneration of infarcted myocardium [10] . The results of this study indicated that resveratrol modified the redox environment in the infarcted heart, which was instrumental for the increased survival of the stem cells.
In 
